Our advice for clinicians on the coronavirus is here.
If you are a member of the public looking for health advice, go to the NHS website. And if you are looking for the latest travel information, and advice about the government response to the outbreak, go to the GOV.UK website.
Innovative image analysis software that creates a 3D model of the heart and could prevent up to 35,000 patients a year undergoing invasive tests will be fast-tracked into use by the NHS.
A surgical suture that reduces the risk of infections like MRSA will also join the NHS scheme to help patients benefit from world leading innovations.
A new type of ‘bowel scope’ and a device that cuts infections caused by catheters complete the four innovations that will be fast-tracked into use through NHS England’s Innovation and Technology Payment programme.
The scheme delivers improvements in patient care by cutting bureaucracy for clinicians and other innovators and encouraging uptake through the NHS.
NHS England has today also announced a nationally backed trial of a technology to cut missed hospital appointments, DrDoctor, as well as a further £1.5 million to pump prime the spread of innovations.
Promising developments are sometimes not adopted because of a lack of evidence to support their use. The money found by NHS England will fund real world evaluation of innovations including DrDoctor which allows patients to reschedule their own appointments rather than miss them.
Simon Stevens, Chief Executive of NHS England, said: “From the very beginning the NHS has been at the forefront of driving innovation, as we celebrate the NHS’s 70th birthday the NHS continues to champion innovation.
“These technologies will improve patient safety and potentially reduce the need for invasive and expensive tests.”
The four innovations are:
- HeartFlow – Advanced image analysis software that creates a 3D model of the coronary arteries and analyses the impact that blockages have on blood flow to rapidly diagnose patients with suspected coronary artery disease. The use of the device can avoid the need for invasive investigations such as coronary angiography, usually carried out under local anaesthetic, where a catheter is passed through the blood vessels to the heart to release a dye before X-rays are taken. NICE estimate up to 35,000 people per year could be eligible.
- Plus Sutures – A new type of surgical suture – stitching – that reduces the rate of surgery-linked infection (surgical site infection) such as MRSA, through the use of antimicrobial suture packs. There were 823 cases of MRSA reported in the NHS in 2016/17.
- Endocuff Vision – A new type of ‘bowel scope’ that improves colorectal examination for patients undergoing bowel cancer tests. Bowel cancer is the fourth most common cancer in England with 34,000 people diagnosed each year. For every 1,000 people screened for cancer, it is estimated that six cases could be avoided thanks to early detection through the use of this device.
- SecurAcath – A device to secure catheters that reduces the infection risk for patients with a peripherally inserted central catheter. The use of this equipment helps to reduce the time taken to care and treat dressing changes. This type of catheter is normally used in people needing intravenous access for several weeks or months in both inpatient and outpatient settings. NICE estimate up to 120,000 people per year could be eligible.
This is the second year of the drive to identify and fast track specific innovations into the NHS, which has already benefitted 75,000 patients.
The NHS’ own innovation agencies – the 15 Academic Health Science Networks across England – will take direct responsibility for accelerating uptake locally.
In an effort to tackle the problem of missed hospital appointments NHS England will support DrDoctor, a digital tool to help patients view, change and schedule appointments, to demonstrate its potential in a real world setting.
Almost eight million hospital appointments were missed in 2016/17, according to the latest figures released by NHS Digital. That does not include appointments cancelled in advance by either the hospital or the patient. With each hospital outpatient appointment costing the NHS approximately £120 in 2016/17, that means almost £1 billion worth of appointments were missed, equivalent to 257,000 hip replacements or 990,000 cataract operations.
Professor Tony Young, National Clinical Lead for Innovation at NHS England, said: “For new innovations to flourish and spread at scale access to funding is critical, by buying these four innovations centrally NHS England has removed the barriers to the spread of these innovations so patients can benefit faster.
“This is just one way in which the NHS is supporting innovation as we celebrate the NHS’ 70th birthday, later this year we will be announcing the next round of doctors, nurses and allied health professionals joining the growing numbers of entrepreneurs developing new and innovative treatments for patients from within the NHS.”